Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation

• Published in: American journal of transplantation Vol. 17; no. 5; pp. 1294 - 1303
• Main Authors: Shino, M. Y., Weigt, S. S., Li, N., Derhovanessian, A., Sayah, D. M., Huynh, R. H., Saggar, R., Gregson, A. L., Ardehali, A., Ross, D. J., Lynch, J. P., Elashoff, R. M., Belperio, J. A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Limited 01.05.2017
• Subjects: Acute Lung Injury - diagnosis; Acute Lung Injury - etiology; Bronchoalveolar Lavage Fluid - chemistry; chemokines/chemokine receptors; clinical research/practice; Female; Follow-Up Studies; Graft Rejection - diagnosis; Graft Rejection - etiology; Graft Survival; Health risk assessment; Humans; immunobiology; Ligands; lung (allograft) function/dysfunction; lung failure/injury; Lung Transplantation - adverse effects; lung transplantation/pulmonology; Male; Middle Aged; Pneumonia; Prognosis; Pulmonary Alveoli - pathology; rejection: acute; rejection: chronic; Retrospective Studies; translational research/science; Transplantation, Homologous; Transplants & implants; lung (allograft) function/dysfunction; rejection: acute; translational research/science; clinical research/practice; lung transplantation/pulmonology; chemokines/chemokine receptors; immunobiology; rejection: chronic; lung failure/injury
• ISSN: 1600-6135; 1600-6143; 1600-6143
• DOI: 10.1111/ajt.14066

The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late‐onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective single‐center study, 1894 transbronchial biopsy samples from 441 lung transplant recipients were reviewed for the presence of acute rejection (AR), lymphocytic bronchiolitis (LB), diffuse alveolar damage (DAD), and organizing pneumonia (OP). The association between the time of onset of each injury pattern and CLAD was assessed by using multivariable Cox models with time‐dependent covariates. Bronchoalveolar lavage (BAL) CXCR3 ligand concentrations were compared between early‐ and late‐onset injury patterns using linear mixed‐effects models. Late‐onset DAD and OP were strongly associated with CLAD: adjusted hazard ratio 2.8 (95% confidence interval 1.5–5.3) and 2.0 (1.1–3.4), respectively. The early‐onset form of these injury patterns did not increase CLAD risk. Late‐onset LB and acute rejection (AR) predicted CLAD in univariable models but lost significance after multivariable adjustment for late DAD and OP. AR was the only early‐onset injury pattern associated with CLAD development. Elevated BAL CXCR3 ligand concentrations during late‐onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response. The authors demonstrate the importance of time‐of‐onset when considering the association between allograft injury and chronic lung allograft dysfunction (CLAD) and report that late‐onset diffuse alveolar damage and organizing pneumonia markedly increase CLAD risk, whereas the early‐onset form of these injury patterns seems to be less important.